"Outcome"@en . "Single nucleotide polymorphisms"@en . . "Efficacy"@en . "French GETUG consortium"@en . "Immune checkpoint inhibitor"@en . . "Prostate cancer"@en . "Small cell bladder cancer"@en . . . "Cancer treatment"@en . . "Radiotherapy"@en . "Adverse event"@en . "Metastatic castration-resistant prostate cancer"@en . "Immune-related adverse events"@en . "Immune checkpoint inhibitors"@en . "Hormone therapy"@en . "Outcomes"@en . . "Angiogenesis inhibitor"@en . . "Combination therapy"@en . "Mitoxantrone"@en . "Prognostic factor"@en . "Adult Aged Antineoplastic Agents"@en . . "St\u00E9phane" . "Immunotherapy"@en . "Elderly"@en . . "Radioimmunotherapy"@en . . . "Taxanes"@en . . "Protective Humans Male Middle Aged Nail Diseases/chemically induced/prevention & control Skin Diseases/chemically induced/prevention & control Taxoids/adverse effects"@en . "Oudard" . . "Prognosis"@en . . "Cancer"@en . "Heterogeneity"@en . "Intensive care"@en . "Abiraterone acetate"@en . "St\u00E9phane Oudard" . "Chemotherapy"@en . "Immunogenic cell death"@en . . "Phytogenic/adverse effects Case-Control Studies Female Freezing Gloves"@en . "Biomarker"@en . "f7789e1b6f2d34d2ad025c9268368814" .